3,4-DIARYLPYRAZOLES AND THEIR USE IN THE THERAPY OF CANCER

Details for Australian Patent Application No. 2002356301 (hide)

Owner RIBOTARGETS LIMITED CANCER RESEARCH TECHNOLOGY LTD. THE INSTITUTE OF CANCER RESEARCH

Inventors DYMOCK, Brian, William; MACDONALD, Edward; PRODROMOU, Chrisostomos; PEARL, Laurence, Harris; WORKMAN, Paul; BARRILALONSO, Xavier; DRYSDALE, Martin, James

Pub. Number AU-A-2002356301

PCT Number PCT/GB02/05778

PCT Pub. Number WO2003/055860

Priority 0130733.9 21.12.01 GB; 0225688.1 04.11.02 GB

Filing date 19 December 2002

Wipo publication date 15 July 2003

International Classifications

A61K 031/415 - 1,2-Diazoles

A61P 035/00 Antineoplastic agents

C07D 231/12 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 0130733.9 21.12.01 GB; 0225688.1 04.11.02 GB

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002356301

9 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356302-PASSIVE BIOLOGICAL SENSOR

2002356300-Cosmetic scar management composition